Press releases

Company Reinforces its Commitment to Achieving Net-Zero Emissions and Supporting Decarbonization Across Operations by Joining Health Sector Climate Pledge FRANKLIN LAKES, N.J. (Dec. 20, 2023) –...

Company Reinforces its Longstanding Commitment to Help Improve Health Equity and Expand Access to Care Among Vulnerable Populations FRANKLIN LAKES, N.J., Dec. 11, 2023 /PRNewswire/ -- BD (Becton,...

BD MiniDraw™ Capillary Blood Collection System Enables Lab-Quality Blood Testing from Less Invasive Method than Venous Collection in More Convenient Locations FRANKLIN LAKES, N.J., Dec. 7, 2023...

FRANKLIN LAKES, N.J. (Dec. 5, 2023) – Today, in recognition of International Volunteer Day 2023, leading global medical technology company, BD (Becton, Dickinson and Company) (NYSE: BDX),...

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it will present the next installment of its BD Innovates series, which will...

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today issued the following statement regarding the U.S. Food and Drug Administration (FDA) Safety...

SiteRite™ 9 Ultrasound System Delivers Enhanced Image Quality and Vessel Assessment Tools to Aid in First Attempt IV Insertion Success FRANKLIN LAKES, N.J., Nov. 30, 2023 /PRNewswire/ -- BD...

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today that Ronald (Ron) Silverman, MD, FACS, has been named executive vice president and...

WASHINGTON, D.C., USA, Nov. 20, 2023 – BD (Becton Dickinson and Company), a leading global medical technology company, and Bio Farma, a state-owned life science company in Indonesia, signed a...

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it will present at the 6th Annual Evercore ISI HealthCONx Conference on Tuesday,...

Execution of BD 2025 Strategy Driving Durable, Broad-Based Growth Q4 revenue of $5.1 billion increased 6.8% as reported and 5.9% on a currency-neutral basis Q4 revenue from base business (which...

The Board of Directors of BD (Becton, Dickinson and Company) (NYSE: BDX) has declared a quarterly dividend of $0.95 per common share, an increase of 4.4% from the previous quarter. The dividend...

New Peripheral Line Draw Solution Delivers First and Only Compatibility with Integrated Catheters, Bringing Elevated Standard of Care to More U.S. Hospitals FRANKLIN LAKES, N.J., Nov. 2, 2023...

Results of the SAFE-DCB Registry support long-term safety and effectiveness for the Lutonix™ DCB in a real-world patient population with femoropopliteal disease.

Company Ranks Top 2 in Healthcare Equipment and Services Industry FRANKLIN LAKES, N.J., Oct. 18, 2023 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical...

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced Greg Rodetis, currently BD senior vice president and treasurer will also add head of...

All Used Injection Devices Recycled; Next Stage of Pilot to Expand Regionally, Add Medical Devices FRANKLIN LAKES, N.J. and RUTLAND, Vt., Oct. 16, 2023 /PRNewswire/ -- BD (Becton, Dickinson and...

BD (Becton, Dickinson and Company) (NYSE:BDX), a leading global medical technology company, today announced that it will report its fiscal 2023 fourth quarter and full year financial results on...

FRANKLIN LAKES, N.J. (Oct. 1, 2023) – BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced Bridget Bagnato has been named president of BD...

Recognition underscores company's commitment to transparency and values FRANKLIN LAKES, N.J., Sept. 19, 2023 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global...

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it will present at the following healthcare conferences: 2023 Wells Fargo...

First patient enrollment in ARCH study begins investigation of the safety and effectiveness of the BD Liverty™ Transjugular Intrahepatic Portosystemic Shunt (TIPS) Stent Graft to reduce...

Increased manufacturing capacity combined with an expansion from 69 to 92 eligible countries, is expected to enable delivery of more than 320 million doses through 2030 Previously guaranteed...

Continues Strong Performance and Progress Toward Achieving BD 2025 Strategy; Advances Innovation Pipeline and Receives Clearance for Updated BD Alaris™ Infusion System Revenue of $4.9 billion...

Single Test on BD MAX™ System Identifies and Differentiates Multiple Respiratory Infectious Diseases from One Sample FRANKLIN LAKES, N.J., Aug. 1, 2023 /PRNewswire/ -- BD (Becton, Dickinson and...

The Board of Directors of BD (Becton, Dickinson and Company) (NYSE: BDX) has declared a quarterly dividend of $0.91 per common share, payable on September 29, 2023 to holders of record on...

Reflects Commitment to Gender Equality and Progress in Advancing ESG Strategy FRANKLIN LAKES, N.J. (July 25, 2023) – BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical...

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the appointment of Dr. Joanne Waldstreicher to its board of directors. Waldstreicher,...

BD (Becton, Dickinson and Company) (NYSE: BDX) Chairman, CEO and President Tom Polen issued the following message regarding the U.S. Food and Drug Administration (FDA) 510(k) clearance for the...

BD Alaris™ Infusion System is the only modular and most comprehensive infusion system on the U.S. market that includes large volume pumps, syringe pumps, patient-controlled analgesia (PCA)...

Company Expands its ESG Focus Areas to Include Advancing Health Equity in Under-Resourced Communities FRANKLIN LAKES, N.J., July 20, 2023 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE:...

FRANKLIN LAKES, N.J. (July 13, 2023) – BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it is one of 200 companies named to U.S....

Top Score on Disability Equality Index Demonstrates Ongoing Progress in Creating Employment Opportunities for People with Disabilities FRANKLIN LAKES, N.J., July 11, 2023 /PRNewswire/ -- BD...

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it will report financial results for its third quarter of fiscal year 2023 on...

FRANKLIN LAKES, N.J. (June 22, 2023) – BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today that Brooke Story has been named president of...

Divestiture Advances BD2025 Strategy to Simplify Portfolio and Focus on Higher-Growth Markets FRANKLIN LAKES, N.J., June 20, 2023 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a...

BD FACSDuet™ Premium System Leverages Robotics to Automate Sample Preparation for Greater Standardization in Clinical Flow Cytometry Diagnostics FRANKLIN LAKES, N.J., June 12, 2023 /PRNewswire/...

Awards and new survey findings represent important milestones on non-profit healthcare consortium’s path to changing expectations around resiliency The following press release was issued by the...

DUBLIN (2 June 2023) – BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today held a grand opening ceremony for a new €4 million research and...

FRANKLIN LAKES, N.J. (June 1, 2023) – BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced that Laura Boros has been named president of...

BD PosiFlush™ SafeScrub Streamlines Clinical Workflow for Disinfecting and Flushing IV Catheters to Help Improve Patient Care FRANKLIN LAKES, N.J., May 23, 2023 /PRNewswire/ -- BD (Becton,...

BD FACSDiscover™ S8 Cell Sorter First to Combine Spectral Flow Cytometry with Real-Time Imaging Technology FRANKLIN LAKES, N.J., May 18, 2023 /PRNewswire/ -- BD (Becton, Dickinson and Company)...

BD Kiestra™ MRSA Imaging Application Helps Enhance Microbiology Laboratory Efficiency and Workflow FRANKLIN LAKES, N.J., May 16, 2023 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE:...

Five organizations are collaborating to evaluate recycling program for blood collection tubes at Odense University Hospital COPENHAGEN, Denmark, May 8, 2023 /PRNewswire/ -- A new health care...

BD 2025 Strategic Investments Driving Growth and Advancing Innovation; Company Raises Mid-point of Revenue and Adjusted EPS Guidance Ranges Revenue of $4.8 billion increased 1.5% as reported and...

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it has been named a "Noteworthy Company" in DiversityInc's annual ranking of the...

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it will present at the Bank of America Securities 2023 Health Care Conference on...

The Board of Directors of BD (Becton, Dickinson and Company) (NYSE: BDX) has declared a quarterly dividend of $0.91 per common share, payable on June 30, 2023 to holders of record on June 9, 2023....

Accolade Represents Positive Perceptions from Employees and Progress in Advancing ESG Strategy FRANKLIN LAKES, N.J., April 25, 2023 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX),...

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today released findings from a survey conducted online by The Harris Poll, reporting that women feel...